Fosun joins Aurobindo, PE firms in final bids for Novartis’ $2B U.S. generics assets: report

11th May 2018 Uncategorised 0

India’s Aurobindo, China’s Fosun Pharma and private equity firms Apollo Global Management and CVC Capital Partners have all been identified as final bidders for some of Norvartis’ U.S. generics assets.

More: Fosun joins Aurobindo, PE firms in final bids for Novartis’ B U.S. generics assets: report
Source: fierce